JPH02224768A - Organism inside/outside communicating member - Google Patents
Organism inside/outside communicating memberInfo
- Publication number
- JPH02224768A JPH02224768A JP1045505A JP4550589A JPH02224768A JP H02224768 A JPH02224768 A JP H02224768A JP 1045505 A JP1045505 A JP 1045505A JP 4550589 A JP4550589 A JP 4550589A JP H02224768 A JPH02224768 A JP H02224768A
- Authority
- JP
- Japan
- Prior art keywords
- plastic
- communication member
- ceramic
- communicating member
- communicating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004033 plastic Substances 0.000 claims abstract description 22
- 229920003023 plastic Polymers 0.000 claims abstract description 22
- 239000000919 ceramic Substances 0.000 claims abstract description 16
- 229910052751 metal Inorganic materials 0.000 claims abstract description 12
- 239000002184 metal Substances 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000010935 stainless steel Substances 0.000 claims abstract description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 3
- 238000004891 communication Methods 0.000 claims description 29
- 229910001069 Ti alloy Inorganic materials 0.000 claims 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical class [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 claims 1
- 238000000576 coating method Methods 0.000 abstract description 9
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 abstract description 6
- 239000011248 coating agent Substances 0.000 abstract description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052586 apatite Inorganic materials 0.000 abstract description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 abstract description 3
- 229910052594 sapphire Inorganic materials 0.000 abstract description 3
- 239000010980 sapphire Substances 0.000 abstract description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract description 2
- 239000005312 bioglass Substances 0.000 abstract description 2
- 229910052715 tantalum Inorganic materials 0.000 abstract description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052719 titanium Inorganic materials 0.000 abstract description 2
- 239000010936 titanium Substances 0.000 abstract description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 abstract 1
- 229910045601 alloy Inorganic materials 0.000 abstract 1
- 239000000956 alloy Substances 0.000 abstract 1
- 239000010952 cobalt-chrome Substances 0.000 abstract 1
- 238000007781 pre-processing Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 description 5
- 238000004544 sputter deposition Methods 0.000 description 4
- 230000005484 gravity Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000007751 thermal spraying Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000005524 ceramic coating Methods 0.000 description 1
- 239000000788 chromium alloy Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、生体の外部と内部な連通ずるための連通部材
に係わる。さらに詳細には、ブラスッチク製の連通部材
に係わる。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a communication member for communicating between the outside and the inside of a living body. More specifically, it relates to a communication member made of brass.
(従来の技術1発明が解決しようとする問題点)最近、
人体等の生体の内部止生体外部とを連通させる必要性が
、医療技術の進歩と共に急激に増大し1例えば外科手術
による体内の器官、臓器等の治療のため、体内へ薬剤、
血液、栄養素1m素等の補給または消毒薬、洗浄剤等の
注入を、−時的または長期間11Mして実施する必要性
が生じてきた。さらに尿や便等の貯蔵、排出の機能を喪
失した場合には腹部に挿入したプラスチック製のチュー
ブ、カテーテル等によって導出し、体外に設置した人工
膀胱1人工肛門等に導いて生体機能を維持させることも
行なわれるようになった。また。(Prior art 1. Problems to be solved by the invention) Recently,
The need for communication between the internal and external organs of living organisms such as the human body has rapidly increased with the advancement of medical technology.
It has become necessary to replenish blood, nutrients, etc., or inject disinfectants, cleaning agents, etc., temporarily or for a long period of time. Furthermore, if the ability to store or excrete urine or feces is lost, the fluid is removed through a plastic tube or catheter inserted into the abdomen and introduced into an artificial bladder, an artificial anus, etc. placed outside the body to maintain biological functions. This also began to be done. Also.
骨髄内部や筋肉深部に薬剤を随時注入したり、洗浄や消
毒等のために体外から洗浄剤や消毒液を注入または排出
する必要も多くなっている。It is increasingly necessary to inject drugs into the bone marrow or deep into the muscles, or to inject or drain cleaning agents or disinfectants from outside the body for purposes such as cleaning and disinfection.
このような時、患者の生体内部と外部を連通ずるため1
食道、気管、腸等を利用しない時は、必要時にその都度
、手術によって生体の一部を切開して、必要部所まで前
記チューブ等の導管を挿入または設置しなければならず
、患者に多大の苦痛を与えるだけでなく、適格な緊急の
処置が極めて困難であり、また問題点も多かった。In such cases, to communicate between the inside and outside of the patient's body,
When the esophagus, trachea, intestines, etc. are not used, it is necessary to surgically incise a part of the body and insert or install a conduit such as the tube to the necessary site each time it is necessary, which causes a great deal of damage to the patient. Not only did this cause pain, but appropriate emergency treatment was extremely difficult and there were many problems.
さらに、食道や気管を利用して、プラスチック製のチュ
ーブを常設し、流動食や空気を補給する場合でも、チュ
ーブと生体とが馴染まないため。Furthermore, even when a plastic tube is permanently placed through the esophagus or trachea to supply liquid food or air, the tube does not mix well with the living body.
その間に隙間が生じて細菌の侵入を招くことがあり、さ
らに生体の拒否反応によって、タダレや潰瘍が発生し易
いという問題点もあった。There are also problems in that gaps may be created between them, inviting the intrusion of bacteria, and furthermore, sagging and ulcers are likely to occur due to rejection by living organisms.
このため、生体の一部を切開して体外から体内に挿入す
る輸送管としてのプラスチック製のチューブを随時、通
過、保持するための連通部材を、生体表面の必要場所に
設置、装着して一時的またはIl続的に5体外から体内
へ薬剤、血液、栄養素。For this reason, a communication member is installed and attached to the necessary location on the surface of the living body to temporarily pass through and hold the plastic tube, which is used as a transport tube that is inserted into the body from outside the body by cutting a part of the living body open. 5. Drugs, blood, and nutrients are transferred from outside the body into the body either directly or continuously.
その他の供給および/または排出を簡便化しかつ衛生的
に実施することは公知であり、このような連通部材とし
て生体に親和性があり、拒絶反応の少ない素材として、
アルミナ、サファイア、ジルコニア、燐酸カルシウム系
等のセラミックスを使用したものが作られている。It is known that other supply and/or discharge can be carried out simply and hygienically, and as such a communication member, a material that is compatible with the living body and has little rejection reaction.
They are made using ceramics such as alumina, sapphire, zirconia, and calcium phosphate.
これらの公知の連通部材は、当初の目的は十分満足でき
るものではあったが、部材の材料が特殊なセラミックス
であったために、比重が大きく、加工性が悪く、高価で
かつ破損し易いという欠点があった。Although these known communication members were fully satisfactory for their original purpose, because the material of the member was a special ceramic, they had the disadvantages of high specific gravity, poor workability, high cost, and easy breakage. was there.
他方、医療用材料に最近頻用されるようになったプラス
チックは、軽量で加工し易いが、生体親和性が少ないか
、または無いものが多く、直接生体に接触させることに
は問題があった。On the other hand, plastics, which have recently become frequently used as medical materials, are lightweight and easy to process, but many have low or no biocompatibility, making it difficult to bring them into direct contact with living organisms.
本発明者は、これらの点について、種々検討と試作を行
なった結果、下記のような発明を完成させた。The present inventor conducted various studies and trial production regarding these points, and as a result, completed the following invention.
(問題点を解決するための手段)
即ち、連通部材の本体を、必要な形状にプラスチックで
成型して構成し、生体に接触する部分にはプラスチック
が露出しないようにし、生体親和性に冨み、拒絶反応が
生じ難い物質で被覆処理して本体のプラスチックと一体
化することができれば、プラスチックの持っている多く
の特徴が活用できることに着目して、この被覆方法の検
討を行なった。(Means for solving the problem) That is, the main body of the communication member is formed by molding plastic into the required shape, the plastic is not exposed in the part that comes into contact with the living body, and the body is highly biocompatible. We investigated this coating method, noting that if we could coat it with a substance that does not cause rejection reactions and integrate it with the plastic of the main body, we could take advantage of the many characteristics of plastic.
従来、金属の薄い被膜を形成させる方法としては、電解
および化学メツキ、真空蒸着、スパッタリングおよび金
属溶射等の方法があるが、最近セラミックスについても
スパッタリング、溶射による被膜形成の技術が完成され
ている。Conventionally, methods for forming thin metal coatings include electrolytic and chemical plating, vacuum evaporation, sputtering, and metal spraying, but recently, techniques for forming coatings on ceramics by sputtering and thermal spraying have been completed.
従って、必要な形状に予め成型または機械加工したプラ
スチック製の連通部材の、露出する全表面または必要と
される表面の一部分に、前記のスパッタリングまたは溶
射のような方法で、セラミックスおよび/または金属を
、プラスチックの部分が完全に、かつ均一に被覆される
ように処理し、さらにこの被覆された金属および/また
はセラミックスがプラスチック本体から容易に剥離しな
いように、プラスチックの表面に被膜の接着を助ける前
処理を行なった。Therefore, ceramics and/or metals may be applied to the entire exposed surface or a portion of the required surface of the plastic communication member, which has been preformed or machined into the required shape, by methods such as sputtering or thermal spraying as described above. , before processing the plastic part so that it is completely and uniformly coated, and also to help the coating adhere to the surface of the plastic so that this coated metal and/or ceramic does not easily peel off from the plastic body. processed.
この連通部材の本体に使用する材料は、ポリアミド、ポ
リカーボネート、アクリル樹脂、その他。The materials used for the main body of this communication member include polyamide, polycarbonate, acrylic resin, and others.
ポリエチレン、ポリプロピレン、ポリスチレン。polyethylene, polypropylene, polystyrene.
ポリ塩化ビニル、ABS、ふっ素樹脂等の熱可塑性樹脂
、およびシリコン樹脂、エポキシ樹脂、フェノール樹脂
、メラミン樹脂、ポリエステル樹脂等の熱硬化性樹脂の
いずれか1種またはそれらの組合わせであってもよく、
被覆材料としては、アルミナ、バイオガラス、サファイ
アジルコニア、アパタイト等のセラミックスおよび/ま
たはステンレス鋼、コバルト−クロム系合金、チタン、
タンタル等の生体親和性のある金属のいずれかが好まし
い。It may be one or a combination of thermoplastic resins such as polyvinyl chloride, ABS, and fluorine resins, and thermosetting resins such as silicone resins, epoxy resins, phenol resins, melamine resins, and polyester resins. ,
Coating materials include ceramics such as alumina, bioglass, sapphire zirconia, and apatite, and/or stainless steel, cobalt-chromium alloys, titanium,
Any biocompatible metal such as tantalum is preferred.
(実施例)
栗11却
上部フランジ部の直径が8m11.下部フランジ部の直
径が161.で内径2.41の孔を有する柱状体の長さ
が5.5■−の連通部材を、ポリカーボネートで射出成
型し、この成型品の孔を除く全表面を洗浄後粗面加工し
た後、ハイドロキシアパタイト微粉末(粒径1001m
、比重3.2)をマグネトロン型スッパッタ装置を用い
、アルゴン雰囲気中。(Example) The diameter of the upper flange part of chestnut 11 is 8 m11. The diameter of the lower flange is 161. A communication member with a length of 5.5 cm and a columnar body having a hole with an inner diameter of 2.41 mm was injection molded with polycarbonate, and the entire surface of this molded product, excluding the hole, was cleaned and roughened, and then treated with hydroxyl. Apatite fine powder (particle size 1001m)
, specific gravity 3.2) in an argon atmosphere using a magnetron type sputtering device.
5.6XIO−’ )−ルの真菟下で3ONm+の厚さ
にコーティング処理して、第1図に示すような連通部材
を得た。A communicating member as shown in FIG. 1 was obtained by coating to a thickness of 3ONm+ under a 5.6XIO-')-hole.
喪施−例一■
実施例■と同じ形状の連通部在をポリエーテルスルフォ
ン〔三井東圧化学■製PE54100G]にて射出成型
し、この表面を実施例■と同様に粗面加工した後、アル
ミニウムを150μIの厚さに真空蒸着させた。この成
型品にハイドロキシアパタイト微粉末(流径100#m
、比重3.2)をプラズマ溶射装置により、アルゴン・
水素プラズマフレームを発生させ、約150μ園の厚さ
になるように多段階溶射処理して第3図に示すような連
通部材を得た。Mourning-Example 1 ■ A communicating part with the same shape as Example ■ was injection molded using polyether sulfone (PE54100G manufactured by Mitsui Toatsu Chemical ■), and the surface was roughened in the same manner as Example ■. Aluminum was vacuum deposited to a thickness of 150 μI. Hydroxyapatite fine powder (flow diameter 100#m) is added to this molded product.
, specific gravity 3.2) was sprayed with argon and
A hydrogen plasma flame was generated and a multi-step thermal spraying process was carried out to obtain a thickness of about 150 μm to obtain a communication member as shown in FIG.
これらの材料で作られた連通部材は、軽量で。Communication members made of these materials are lightweight.
丈夫で、生体親和性に冨み、かつ生体拒絶反応が少なく
、形状が多彩でしかも安価であり、追加加工も容易にで
きるという利点がある。It has the advantages of being strong, highly biocompatible, less susceptible to biological rejection, available in a variety of shapes, inexpensive, and easy to perform additional processing.
本発明は、さらにこの連通部材が固定用の孔を。The present invention further provides that the communication member has a fixing hole.
体内挿入部の下部フランジ部分に有しており、この連通
部材が、使用中に移動したり、潜入したり。The communication member is located on the lower flange of the body insertion part and does not move or sneak in during use.
傾斜して外部から細菌等が接近、侵入するのを防止でき
るようになっている。It is tilted to prevent bacteria from approaching and entering from the outside.
第1図は、プラスチック成型品の孔を除く全表面をセラ
ミックスで被覆処理した、本発明に基づく生体内外連通
部材の断面図である。
第2国は、プラスチック成型品の柱状部の外向と下部7
ランジ部の一ヒ面のみをセラミックスで被覆処理した、
本発明に基づく生体内外連通部材の断面図である。
第3図は、第2図に示した連通部材のセラミックス被覆
処理層とプラスチック本体の中間に金属プレートを装着
した、本発明に基づく生体内外連通部材の断面図である
。
第4A図および第4B図は、第2図に示す連通部材の下
部フランジ部に3個の貫通孔を設けたところを示す断面
図および底面図である。
添付図面において。
l・・・プラスチック本体、 2・・・セラミック層
。
3・・・金属プレート層、 4・・・上部7ランジ部
5・・・下部7ランジ部、 6・・・柱状部、7・・
・貫通孔。
図面の浄?(内容に変更なし)
第1図 第2図
第3図
第4A図
第4B図FIG. 1 is a sectional view of an in-vivo communication member based on the present invention, in which the entire surface of the plastic molded product except for the holes is coated with ceramics. The second country is the outer and lower part of the columnar part of the plastic molded product.
Only one side of the lunge part is coated with ceramics.
FIG. 2 is a cross-sectional view of an in-vivo communication member according to the present invention. FIG. 3 is a sectional view of the in-vivo communication member according to the present invention, in which a metal plate is mounted between the ceramic coating layer and the plastic body of the communication member shown in FIG. 4A and 4B are a sectional view and a bottom view showing three through holes provided in the lower flange portion of the communication member shown in FIG. 2. FIG. In the accompanying drawings. l...Plastic body, 2...Ceramic layer. 3... Metal plate layer, 4... Upper 7 flange portion 5... Lower 7 lange portion, 6... Column shaped portion, 7...
・Through hole. The purity of the drawing? (No change in content) Figure 1 Figure 2 Figure 3 Figure 4A Figure 4B
Claims (5)
用連通部材であって、前記連通部材がプラスチックでで
きており、前記連通部材の露出する外面の全部または一
部が生体親和性セラミックスでできた層で被覆、一体化
されていることを特徴とする生体内外連通部材。(1) A hollow columnar biological communication member having flanges at both upper and lower ends, the communication member being made of plastic, and all or part of the exposed outer surface of the communication member being made of biocompatible ceramics. A communication member inside and outside a living body, characterized in that it is covered and integrated with a layer made of the same material.
て、前記連通部材の露出する外面の中、柱状部の外面お
よび下方フランジ部の上面が、前記生体親和性セラミッ
クスでできた層で被覆、一体化されていることを特徴と
する生体内外連通部材。(2) The communicating member according to claim 1, wherein the exposed outer surface of the communicating member, the outer surface of the columnar part, and the upper surface of the lower flange part are a layer made of the biocompatible ceramic. A communication member inside and outside a living body, characterized in that it is coated and integrated with.
、前記連通部材のセラミックス層と前記連通部材との中
間に、さらに金属プレートを一体化して挿入したことを
特徴とする生体内外連通部材。(3) The communicating member according to claim 2, characterized in that a metal plate is further integrated and inserted between the ceramic layer of the communicating member and the communicating member. Communication member.
に記載の連通部材であって、前記下方フランジ部が、少
なくとも1個以上の貫通孔を有することを特徴とする生
体内外連通部材。(4) The communication member according to any one of claims 1 to 3, wherein the lower flange portion has at least one through hole. Communication member.
、前記金属プレートが、ステンレス鋼、コバルト−クロ
ム合金、またはチタン合金よりなるグループより選択さ
れた1種でできていることを特徴とする生体内外連通部
材。(5) The communication member according to claim 3, wherein the metal plate is made of one material selected from the group consisting of stainless steel, cobalt-chromium alloy, or titanium alloy. Features: A communication member inside and outside the body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1045505A JPH02224768A (en) | 1989-02-28 | 1989-02-28 | Organism inside/outside communicating member |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1045505A JPH02224768A (en) | 1989-02-28 | 1989-02-28 | Organism inside/outside communicating member |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02224768A true JPH02224768A (en) | 1990-09-06 |
Family
ID=12721270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1045505A Pending JPH02224768A (en) | 1989-02-28 | 1989-02-28 | Organism inside/outside communicating member |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02224768A (en) |
-
1989
- 1989-02-28 JP JP1045505A patent/JPH02224768A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6994883B2 (en) | Method for applying a bioactive coating on a medical device | |
EP1800699B1 (en) | Scaffold material capable of inducing biological hard tissue or soft tissue | |
CN202335944U (en) | Novel medical supply | |
WO2001043790A3 (en) | Medical article with a diamond-like carbon coating | |
EP2747798B1 (en) | Bio-compatible container | |
SI20847A (en) | Process and device for facilitating the implantation of biological material | |
CA2388153A1 (en) | Biocompatible article | |
DE59903659D1 (en) | Process for the surface coating of medical implants | |
US6042909A (en) | Encapsulation device | |
CN114601602B (en) | Implant prosthesis | |
NL1016040C2 (en) | Porous cell attachment material, method for its manufacture, and applications. | |
US20080234563A1 (en) | Device for and Method of Delivery and Removal of Substances in and From a Tissue or Vessel | |
US11633583B2 (en) | Implantable interface device | |
ES2361443T3 (en) | ANTIMICROBIAL COATING PROCEDURES. | |
US9433748B2 (en) | Bio-compatible catheter | |
CA2363119A1 (en) | Hemocompatible surfaces and method for producing same | |
JPH02224768A (en) | Organism inside/outside communicating member | |
Burny et al. | Biomaterials education: a challenge for medicine and industry in the late 1990s | |
Ye et al. | Implementing tissue engineering and regenerative medicine solutions in medical implants | |
CN107510501B (en) | Bone fracture plate | |
EP3603572A1 (en) | Method for endothelializing vascular prostheses | |
US5569194A (en) | Device for permanent connection between an abdominal wall and an abdominal cavity | |
KR20190117863A (en) | Method for preparation of ePTFE-based artificial vessels with enhanced hemocompatibility via selective plasma etching | |
Han | Osteoblast responses to different surface morphology and roughness of 3D-printed PEEK implants and prosthesis | |
Bambauer et al. | Surface Treated Catheters for Vascular Access in Extracorpo-real Detoxification Methods are Needed |